Industry Giants Gilead Sciences, Bristol Myers Squibb, AbbVie, and Merck & Co. Lead the CompetitionDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Viral hepatitis is a descriptive medical term for liver infection caused by hepatitis viruses of which the most significant ...

Hepatitis C virus (HCV) and nonalcoholic fatty liver disease (NAFLD) are the two most common causes of chronic liver disease in North America. NAFLD represents a spectrum of liver lesions that ...

Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

What causes liver disease? Causes of liver disease include viral infections like hepatitis B or C, long-term alcohol use, genetics, certain medications, and fat that builds up in the liver.

New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

Women with cirrhosis might notice their belly becoming swollen or bloated. This swelling is called ascites and happens ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

The Cambridgeshire man's mum had both Hepatitis B and C and her health suffered for many years as a result of it.